How New Therapies Are Changing The Future of Myeloma

Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope for the future. In this episode, we speak to Dr. Nishi Shah of Montefiore Einstein Comprehensive Cancer Center in New York City. While the wide variety of therapies available to patients are discussed, this episode also focuses on the newest, cutting-edge therapies for myeloma, such as CAR T-cell therapy and bispecific antibodies.

Mentioned on this episode:

• Multiple Myeloma
• CAR T-cell Therapy
• Bispecific Antibodies – Immunotherapy Booklet
• Stem Cell Transplant
• Multiple Myeloma and Agent Orange

Additional LLS Support Resources:

• Information Specialists
• Financial support
• Free telephone/web patient programs
• Free booklets
• Clinical Trial Support Center
• Young Adult Resources
• Caregiver support
• Caregiver Workbook
• Survivorship Workbook
• Online chats
• LLS Community
• Support groups
• Patti Robinson Kaufmann First Connection Program
• Free Nutrition Consultations

Support for this episode provided by: AbbVie Inc.; Genentech, Inc. & Biogen; and Johnson & Johnson.

The post How New Therapies Are Changing The Future of Myeloma first appeared on The Bloodline with Blood Cancer United Podcast.